A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes
Clinical trial NCT06385327 · COMPLETED
Trial details
- NCT number
- NCT06385327
- Sponsor
- Assembly Biosciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-30
- Primary completion
- 2026-02-03
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.